Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CG Oncology, Inc. | Director | Common Stock | 3M | $84.1M | $28.00 | Dec 16, 2024 | By Charming Jade Limited |
CG Oncology, Inc. | Director | Common Stock | 614K | $17.2M | $28.00 | Dec 16, 2024 | Direct |
CG Oncology, Inc. | Director | Common Stock | 587K | $16.4M | $28.00 | Dec 16, 2024 | By Unique Diamond Investments Limited |
CG Oncology, Inc. | Director | Stock Option (Right to Buy) | 15.6K | Oct 4, 2024 | Direct | ||
CG Oncology, Inc. | Director | Series B Preferred Stock | 0 | Jan 29, 2024 | Direct | ||
CG Oncology, Inc. | Director | Series C Preferred Stock | 0 | Jan 29, 2024 | By Unique Diamond Investments Limited | ||
CG Oncology, Inc. | Director | Series D Preferred Stock | 0 | Jan 29, 2024 | By Unique Diamond Investments Limited | ||
CG Oncology, Inc. | Director | Series E Preferred Stock | 0 | Jan 29, 2024 | By Charming Jade Limited |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CGON | CG Oncology, Inc. | Dec 16, 2024 | 1 | -$19.6M | 4 | Dec 17, 2024 | Director |
CGON | CG Oncology, Inc. | Oct 4, 2024 | 1 | $0 | 4 | Oct 7, 2024 | Director |
CGON | CG Oncology, Inc. | Aug 29, 2024 | 2 | -$23M | 4 | Aug 30, 2024 | Director |
CGON | CG Oncology, Inc. | Jan 29, 2024 | 8 | $5M | 4 | Jan 31, 2024 | Director |
CGON | CG Oncology, Inc. | Jan 24, 2024 | 0 | $0 | 3 | Jan 24, 2024 | Director, 10%+ Owner |